PDS Biotechnology Corporation (PDSB)

PDS0101 Triple Combination Data To Be Presented At ASCO


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
May 31, 2022
Report ID: 24917
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


PDS Biotechnology Corporation
PDS Biotechnology Corporation
Healthcare
Biotechnology
Ticker
PDSB
Current Price
$8.47 0.59%
Market Cap
$241.5M
Price Target
Refer to Report
Volume
234.9K
52wk Range
$2.89 - $10.5484
Related Research Reports
11/15/2022

PDS Bio Reports 3Q22 and Reviews Full SITC Data
PDS Bio Reports 3Q22 and Reviews Full SITC Data (PDSB)
11/8/2022

SITC Abstracts Released For Two Studies
SITC Abstracts Released For Two Studies (PDSB)
10/27/2022

KOL Event Held To Discuss Head and Neck Cancer
KOL Event Held To Discuss Head and Neck Cancer (PDSB)
10/12/2022

Interim Update From Triple-Therapy Trial Shows Continued Survival Benefit
Interim Update From Triple-Therapy Trial Shows Continued Survival Benefit (PDSB)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.